Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo

11 Oct 2012

Abstract excerpt

Actinomycin D plays a key role in the successful treatment of Wilms tumour. However, associated liver toxicities remain a drawback to potentially curative treatment. We have used MDCKII cells over-expressing ABCB1, ABCC1, ABCC2 and ABCG2, alongside knockout mouse models to characterise actinomycin D transport and its impact on pharmacokinetics. Growth inhibition, intracellular accumulation and cellular efflux...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Drug Transport and Resistance Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23063411
DOI: 10.1016/j.bcp.2012.10.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivoPMID 23063411Read ↗

The role of solute carrier (SLC) transporters in actinomycin D pharmacokinetics in paediatric cancer patients.Semantic proximity Read ↗

Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.Semantic proximity Read ↗

Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoproteinSemantic proximity Read ↗

Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoproteinSemantic proximity Read ↗

Generation and Characterization of an Abcc1 Humanized Mouse Model (hABCC1) with Knockout CapabilitySemantic proximity Read ↗

Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2Semantic proximity Read ↗

Zebrafish Abcg2a mutant line as an in vivo model for evaluation of the interaction of Abcg2a with drugs and contaminants.Semantic proximity Read ↗

Characterization and tissue localization of zebrafish homologs of the human <i>ABCB1</i> multidrug transporterSemantic proximity Read ↗

A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux StudiesSemantic proximity Read ↗

Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.Semantic proximity Read ↗

Overlapping Functions of ABC Transporters in Topotecan Disposition as Determined in Gene Knockout Mouse ModelsSemantic proximity Read ↗

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.